Concepedia
Statistics
Publications
8
Citations
409
H-Index
Active since
2012
Affiliations
Incyte (United States)(Current)
University of Pennsylvania
Villanova University
Michael T. Peel is an author at Incyte (United States) specializing in pharmacology, medicine, and jak inhibitor therapy.
Publications per year
2012–2021
Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy
Eduardo Huarte, Roddy S. O’Connor, Michael T. Peel et al. · Clinical Cancer Research · 2020 · 93 citations · Full text
Medicine, Oncology, Pharmacology +17
Single-cell transcriptomic analysis of adult mouse pituitary reveals sexual dimorphism and physiologic demand-induced cellular plasticity
Yugong Ho, Peng Hu, Michael T. Peel et al. · Protein & Cell · 2020 · 92 citations · Full text
Life Sciences, Cell Biology, Endocrinology +17
Genome-Wide Characterization of the Phosphate Starvation Response in Schizosaccharomyces pombe
Ian Carter-O’Connell, Michael T. Peel, Dennis D. Wykoff et al. · BMC Genomics · 2012 · 87 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +16
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases
Maryanne Covington, Xin He, Monika Scuron et al. · European Journal of Pharmacology · 2020 · 47 citations
Medicine, Medicinal Chemistry, Pharmacology +12
Ruxolitinib, a JAK1/2 Inhibitor, Ameliorates Cytokine Storm in Experimental Models of Hyperinflammation Syndrome
Eduardo Huarte, Michael T. Peel, Katherine Verbist et al. · Frontiers in Pharmacology · 2021 · 41 citations · Full text
Medicine, Immunology, Pharmacology +17
1–5 of 8